Welcome! The Huntington Study Group (HSG) is a non-profit group of clinical investigators from medical centers in the United States, Canada, Europe and Australia, experienced in the care of patients and families affected by Huntington disease and dedicated to clinical research of this hereditary disorder. The HSG focuses on the conception, conduct and communication of clinical research, including treatment trials and observational studies aimed at relieving the burden and slowing the progression of Huntington disease. Please see Clinical Trials and Observational Studies in Progress for the current HSG trials.

 


UPCOMING TRIALS
July 2009 - CREST-E and HORIZON will soon be enrolling. Please check back for updates on these and other potential future trials.

ENROLLING TRIALS AND STUDIES
July 2009 - The treatment trials that are currently enrolling 2CARE, HART and PREQUEL.
July 2009 - The observational studies that are currently enrolling are COHORT and PREDICT-HD.
Please see Clinical Trials and Observational Studies in Progress for a list of all ongoing HSG trials.

3RD ANNUAL HUNTINGTON DISEASE CLINICAL RESEARCH SYMPOSIUM
REGISTRATION IS NOW OPEN for the 3rd Annual Huntington Disease Clinical Research Symposium taking place in Baltimore, Maryland on Saturday, November 21, 2009. Regular abstracts will be accepted until Friday, July 31, 2009, and late-breaking abstracts until Friday, September 4, 2009. Please visit their web site, and view the Preliminary Program and Call for Abstracts for more information.

MEET THE HSG STAFF
We are pleased to introduce you to the HSG Staff members.
  
A Closer Look...

This is an exciting and busy time for HD researchers and the community. The Huntington Study Group has 7 studies that are either enrolling, or soon to be enrolling participants. Please see the HSG Study Flyer for a detailed chart view of these enrolling studies and clinical trials. Feel free to print the information and discuss it with your family, friends and medical professionals.